12:00 AM
 | 
Sep 07, 2009
 |  BC Week In Review  |  Company News  |  Deals

New Zealand Pharmaceuticals Ltd., Summit deal

Summit Corp. sold its chemistry services subsidiary Dextra Laboratories Ltd. to CMO New Zealand for £950,000 ($1.6 million) in cash. New Zealand Pharmaceuticals said Dextra's contract synthesis and...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >